What is the global market size of Mental Health Market?

Mental Health Market size was valued at USD 386.10 billion in 2021 and is poised to grow from USD 399.61 billion in 2022 to USD 526.21 billion by 2030, at a CAGR of 3.5% during the forecast period (2023-2030).

Who are the key vendors in the Global Mental Health Market?

The global mental health market is highly competitive and fragmented, with several major players competing for market share. There are several smaller companies and startups operating in the mental health market. These companies are focused on developing innovative new treatments and technologies for mental health disorders, and are often able to move more quickly and adapt more easily to changing market conditions. Overall, the competitive landscape in the mental health market is rapidly evolving, with new players and technologies entering the market all the time. 'Pfizer Inc. (US)', 'Johnson & Johnson (US)', 'Eli Lilly and Company (US)', 'Bristol-Myers Squibb (US)', 'GlaxoSmithKline (UK)', 'AstraZeneca (UK)', 'Allergan plc (Ireland)', 'Merck & Co., Inc. (US)', 'Takeda Pharmaceutical Company Limited (Japan)', 'Otsuka Holdings Co., Ltd. (Japan)', 'Novartis International AG (Switzerland)', 'Sanofi S.A. (France)', 'Lundbeck A/S (Denmark)', 'Teva Pharmaceutical Industries Ltd. (Israel)', 'Mylan N.V. (Netherlands)', 'AbbVie Inc. (US)', 'Boehringer Ingelheim International GmbH (Germany)', 'H. Lundbeck A/S (Denmark)', 'Sun Pharmaceutical Industries Ltd. (India)', 'Alkermes plc (Ireland)'

What is the key driver of Global Mental Health Market?

The rising incidence of mental health disorders such as depression, anxiety, and substance abuse are a major driver of the global mental health market. This has resulted in a growing demand for mental health services and treatments, driving market growth.

What is the key market trend for Global Mental Health Market?

Increasing Use of Telemedicine: Telemedicine has emerged as a key trend in the mental health market. Telemedicine offers remote mental health services, such as teletherapy and telepsychiatry, that can be accessed from anywhere using a smartphone or computer. It is more accessible and convenient for patients, particularly those in rural or remote areas, and can also be cost-effective. Some examples of companies providing telemedicine services in the mental health market include Teladoc Health and Amwell.

Which region accounted for the largest share in Global Mental Health Market?

North America dominates the global mental health market, with the United States being the largest market in the region. The high prevalence of mental health disorders, growing awareness about mental health, and increasing healthcare expenditure are driving the growth of the market in this region. The North American market is characterized by a high level of competition among key players, with a focus on research and development of new treatments and therapies for mental health disorders.

Mental Health Market Size, Share, Growth Analysis, By Application(Physiological Disorder(Depression, Anxiety, Post-Traumatic Stress Disorder (PTSD), Bipolar Disorder), By By Technology(Self-Screening Mental Health Apps, Telehealth And virtual Care Solutions, Continuous Monitoring Wearable Devices, AI Based Screening Tools), By Age Group(Children And Adolescents, Adults, Seniors), By Setting(Clinical Setting, Educational Institutions, Workspace Slash Corporate Programs, Online Platforms), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2233 | Region: Global | Published Date: August, 2024
Pages: 219 | Tables: 65 | Figures: 75

Mental Health Market Regional Insights

Growing awareness regarding mental health and increasing emphasis on improving mental health of individuals are projected to help North America dominate the global market growth. Rising consciousness about the importance of mental health, growing availability of mental health care, and rising acceptance of the same are slated to bolster the demand for mental health in the future. Canada and the United States will remain the most opportune markets for mental health companies in this region. A growing geriatric population will also play a crucial role in augmenting mental health demand.

Europe is predicted to account for the second-largest share of the global mental health market. Surging prevalence of mental health disorders in this region and growing availability of mental health services are projected to help market growth in Europe. The United Kingdom, France, Italy, and Germany are slated to be the most opportune markets for mental health providers in this region. The region is home to some of the best mental health care services in the world and increasing efforts of governments to promote mental health are also helping mental health demand in this region.

Mental Health Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Mental Health Market size was valued at USD 399.61 billion in 2022 and is poised to grow from USD 413.60 billion in 2023 to USD 544.63 billion by 2031, at a CAGR of 3.5% during the forecast period (2024-2031).

Mental health providers should focus on creating campaigns and working with public health organizations and governments to improve awareness regarding mental health. Incorporating telemedicine and telehealth practices for mental health will be crucial in determining the success of any mental health company operating in this market. Mental health mobile applications are projected to bring in substantial revenue for mental health companies in the long run. 'Pfizer Inc. (US) ', 'Johnson & Johnson (US) ', 'Eli Lilly and Company (US) ', 'Bristol-Myers Squibb (US) ', 'GlaxoSmithKline (UK) ', 'AstraZeneca (UK) ', 'Merck & Co., Inc. (US) ', 'Takeda Pharmaceutical Company Limited (Japan) ', 'Otsuka Holdings Co., Ltd. (Japan) ', 'Novartis International AG (Switzerland) ', 'Sanofi S.A. (France) ', 'Lundbeck A/S (Denmark) ', 'Teva Pharmaceutical Industries Ltd. (Israel) ', 'AbbVie Inc. (US) ', 'Boehringer Ingelheim International GmbH (Germany) ', 'H. Lundbeck A/S (Denmark) ', 'Sun Pharmaceutical Industries Ltd. (India) ', 'Alkermes plc (Ireland) ', 'Amgen Inc. (US) ', 'Gilead Sciences, Inc. (US) ', 'Hikma Pharmaceuticals PLC (UK) ', 'Jazz Pharmaceuticals plc (Ireland) '

People have become more aware of the importance of mental health owing to efforts of non-profit organizations and governments. This surge in awareness regarding mental health around the world is projected to bolster the demand for mental health solutions and services going forward.

Digital Mental Health Apps: Mental health companies can focus on the development of novel mental health applications that can help people detect, manage, or treat their mental health disorders. Moreover, this can improve the accessibility to mental health care for more people than ever before and boost revenue generation as well.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Mental Health Market Regional Insights

Mental Health Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Mental Health Market?

Who are the key vendors in the Mental Health Market?

What is the key driver of Mental Health Market?

What is the key market trend for Mental Health Market?

Which region accounted for the largest share in Mental Health Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300